Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Gemigliptin on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Nephropathy: A Randomized Controlled Trial

NCT04705506 is registered in ClinicalTrials.gov with Bangkok Metropolitan Administration Medical College and Vajira Hospital as lead sponsor.

NCT NCT04705506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Gemigliptin on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Nephropathy: A Randomized Controlled Trial
Lead sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2017
Completion date
March 1, 2019
Enrollment
201 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathies